Current Perspectives on Treating Patients with LARC

Article Figures & Data

Figures

  • Figure 1.

    Patient and Oncologist Treatment Preferences Differ

    PRT, preoperative radiotherapy.Reprinted by permission from Macmillan Publishers Ltd: British Journal of Cancer. Pieterse AH et al. Benefit from preoperative radiotherapy in rectal cancer treatment: disease-free patients' and oncologists' preferences. 2007;97:717–724, Copyright 2007.
  • Figure 2.

    Results of the ADORE Trial: Disease-Free Survival

    Reprinted from The Lancet Oncology, 15:1245–1253, Hong YS et al, Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomized controlled trial, Copyright 2014, with permission from Elsevier.
  • Figure 3.

    Results of the ADORE Trial: Overall Survival

    Reprinted from The Lancet Oncology, 15:1245–1253, Hong YS et al, Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomized controlled trial, Copyright 2014, with permission from Elsevier.